According to Dermapharm's latest financial reports the company's current EPS (TTM) is 2,16 โฌ. In 2022 the company made an earnings per share (EPS) of 2,38 โฌ a decrease over its 2021 EPS that were of 4,11 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | 2,28 โฌ | -4.07% |
2022 | 2,38 โฌ | -42.21% |
2021 | 4,11 โฌ | 144.18% |
2020 | 1,68 โฌ | 14.58% |
2019 | 1,47 โฌ | -3.15% |
2018 | 1,52 โฌ | -34.2% |
2017 | 2,31 โฌ |